BioNTech SE BNTX
NASDAQ BNTX
$116.57 +5.68 (+5.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) Goodwill & Intangibles (2018 - 2025)

BioNTech SE (BNTX) posted Goodwill & Intangibles of $2.3 billion for Q4 2025, up 12.47% sequentially from $2.0 billion in Q3 2025, and up 83.62% YoY from $1.3 billion in Q4 2024.

BioNTech SE (BNTX) Goodwill & Intangibles (2018 - 2025) Analysis & Trends

BioNTech SE has reported Goodwill & Intangibles for 8 years, with the latest figure at $2.3 billion in Q4 2025.

  • Quarterly Goodwill & Intangibles rose 83.62% year-over-year to $2.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 billion (up 83.62% YoY) and the FY2025 annual result came in at $2.2 billion, up 78.22% from the prior year.
  • Goodwill & Intangibles rose to $2.3 billion in Q4 2025 per BNTX's latest filing, from $2.0 billion in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $2.3 billion in Q4 2025 and troughed at $192.1 million in Q3 2021.
  • A 5-year average of $950.7 million and a median of $834.2 million in 2023 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2023 and 2024: Goodwill & Intangibles jumped 392.15% in 2023, then slipped 9.39% in 2024.
  • Over 5 years, Goodwill & Intangibles stood at $294.2 million in 2021, then climbed by 2.85% to $302.6 million in 2022, then jumped by 356.36% to $1.4 billion in 2023, then retreated by 9.39% to $1.3 billion in 2024, then jumped by 83.62% to $2.3 billion in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $2.3 billion, $2.0 billion, and $2.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Roivant Sciences 26.20 Bn 26.20 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.30 Bn
Sep 30, 2025 2.04 Bn
Jun 30, 2025 2.10 Bn
Mar 31, 2025 1.99 Bn
Dec 31, 2024 1.25 Bn
Sep 30, 2024 1.37 Bn
Jun 30, 2024 1.33 Bn
Mar 31, 2024 1.29 Bn
Dec 31, 2023 1.26 Bn
Sep 30, 2023 1.12 Bn
Jun 30, 2023 545.99 Mn
Mar 31, 2023 406.37 Mn
Dec 31, 2022 302.61 Mn
Sep 30, 2022 228.07 Mn
Jun 30, 2022 236.25 Mn
Mar 31, 2022 242.42 Mn
Dec 31, 2021 294.23 Mn
Sep 30, 2021 192.11 Mn
Jun 30, 2021 197.62 Mn
Mar 31, 2021 199.27 Mn